- Q4 2023 Amylyx Pharmaceuticals Inc Earnings Call TranscriptFeb 22, 2024$18.54 (+21.10%)Earnings
- Q3 2023 Amylyx Pharmaceuticals Inc Earnings Call TranscriptNov 09, 2023$12.26 (-31.89%)Earnings
- Amylyx Pharmaceuticals Inc at Morgan Stanley Global Healthcare Conference TranscriptSep 12, 2023
- Q2 2023 Amylyx Pharmaceuticals Inc Earnings Call TranscriptAug 10, 2023$21.17 (-1.49%)Earnings
- Amylyx Pharmaceuticals Inc To Host Virtual Webcast on AMX0035 Progressive Supranuclear Palsy (PSP) Program TranscriptJul 26, 2023
- Amylyx Pharmaceuticals Inc at Goldman Sachs Healthcare Conference TranscriptJun 13, 2023
- Amylyx Pharmaceuticals Inc Annual Shareholders Meeting TranscriptJun 08, 2023
- Q1 2023 Amylyx Pharmaceuticals Inc Earnings Call TranscriptMay 11, 2023$28.82 (-0.41%)Earnings
- Amylyx Pharmaceuticals Inc at Needham Healthcare Conference (Virtual) TranscriptApr 18, 2023
- Amylyx Pharmaceuticals Inc at Stifel CNS Days (Virtual) TranscriptMar 28, 2023
- Q4 2022 Amylyx Pharmaceuticals Inc Earnings Call TranscriptMar 13, 2023$31.17 (+1.66%)Earnings
- Amylyx Pharmaceuticals Inc at SVB Securities Global Biopharma Conference (Virtual) TranscriptFeb 14, 2023
- Amylyx Pharmaceuticals Inc at Evercore ISI HealthCONx Conference (Virtual) TranscriptNov 29, 2022
- Q3 2022 Amylyx Pharmaceuticals Inc Earnings Call TranscriptNov 10, 2022$35.39 (+2.25%)Earnings
- Amylyx Pharmaceuticals Inc RELYVRIOâ„¢ FDA Approval Call TranscriptSep 30, 2022
- Amylyx Pharmaceuticals Inc Annual Shareholders Meeting TranscriptJun 09, 2022
Q4 2023 Amylyx Pharmaceuticals Inc Earnings Call Transcript
Good morning. My name is Jenny, and I will be your conference operator today. At this time, I would like to welcome everyone to the Analex Pharmaceuticals Fourth Quarter and Full Year 2023 earnings conference call. All participants will be in a listen only mode.
After today's presentation, there will be an opportunity to ask questions. (Operator Instructions) Please be advised that this call is being recorded at the company's request. I would now like to turn the call over to Lindsey Allen, Head, Investor Relations and Communications. Please proceed.
Good morning, and thank you for joining us today to discuss our fourth quarter and full year 2023 earnings. with me on the call are Josh Cohen and Justin Klee our co-CEOs, James Frates, our Chief Financial Officer, and Dr. Camille Bedrosian, our Chief Medical Officer.
Before we begin, I would like to remind everyone that any statements we make or information presented on this call that are not historical facts are
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
![](https://static.gurufocus.com/material/money-back-guarantee.png)
![](https://static.gurufocus.com/trust_rating.png)
![](https://static.gurufocus.com/trust.png)